DIH Executes 1-for-25 Reverse Split as Shares Plunge 49%

Introduction

DIH HOLDINGS US INC (NASDAQ: DHAI) is a global provider of rehabilitation technology. Founded through the consolidation of niche innovators, the company designs, manufactures, and distributes robotic and interactive devices for hospitals, clinics, research institutions, and home use. Its offerings support patients with walking impairments, balance issues, and upper-limb dysfunction.

Corporate Structure and Leadership

Headquartered in Volketswil, Switzerland, DIH employs between 201 and 500 people across research, manufacturing, sales, and support functions. The leadership team combines more than two decades of industry experience:

• Jason [Surname], Chief Executive Officer and Chairman, holds an Executive Master from Kellogg School of Management and an MBA from CEIBS. He has led global operations at Cardinal Health and GE.
• Ms. Bass, Chief Financial Officer since March 2023, is a Certified Public Accountant with a BBA in Accounting from Harding University. She has prior experience at Deloitte & Touche, NaturChem Inc., and Rather Outdoors Corporation.
• Thomas [Surname], Chief Technology Officer since 2021, has extensive R&D and software development expertise from his roles leading global development projects at Hocoma and DIH.

Rehabilitation technology by ThisisEngineering

Developments and News

On October 16, 2025, DIH announced a 1-for-25 reverse stock split of its Class A common stock, effective at market open on October 20, 2025 (CUSIP 23290B205). Shares outstanding were reduced from approximately 52.3 million to 2.09 million, with no change to par value or authorized share counts. Stockholders holding electronic shares required no action; holders of paper certificates were offered exchanges through Continental Stock Transfer & Trust Company.
The company filed two Current Reports on Form 8-K: one on October 20, 2025 (items 2.02 and 9.01) and another on October 21, 2025 (items 1.01, 3.02, and 9.01). A further 8-K filed on November 6, 2025 (items 3.01 and 8.01) disclosed material events and updates, though details were not publicly excerpted.

Financial and Strategic Analysis

On November 6, 2025, DIH shares closed at $0.9249, down 49.18% from the prior session, with 117,376 shares traded. According to Yahoo Finance data as of October 20, 2025:

• Market Capitalization (intraday): $185.2 million
• Revenue (TTM): $69.57 million
• Net Income (TTM): –$10.29 million (–14.79% profit margin)
• EPS (TTM): –$9.08
• Return on Assets (TTM): –4.63%
• Price/Sales (TTM): 0.08
• Enterprise Value/Revenue: 0.37

These metrics reflect the company's position in a capital-intensive industry with ongoing investments in R&D and global distribution. The reverse split was implemented to align the company with Nasdaq listing standards and consolidate the trading float.

Market Position and Industry Context

DIH operates in a fragmented rehabilitation technology market alongside established med-tech firms and emerging robotics specialists. Its integrated product portfolio—including brands acquired through mergers—addresses the full continuum of care from acute hospital settings to home-based therapy. Strategic initiatives emphasize partnerships with academic and clinical research centers, while sales efforts target distributors and end-users across North America, Europe, and Asia. The company’s low beta (0.02) suggests limited stock volatility relative to the S&P 500, despite ongoing challenges with negative earnings and efforts toward revenue growth and cost management.

tl;dr

On October 16, 2025, DIH announced a 1-for-25 reverse stock split effective October 20 to consolidate its share structure. Following two Form 8-K filings in late October and a third on November 6, share price fell 49.18% to $0.9249 on November 6, 2025. Trailing twelve-month revenue stood at $69.57 million against a net loss of $10.29 million. The company aims to leverage its integrated rehabilitation robotics portfolio and global distribution network to drive future revenue growth while aligning its capital structure with Nasdaq requirements.